Prof. Giovanni Barbara

MUCOSAL IMMUNE BIOMARKERS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
2013-01-01
English, Irritable Bowel Syndrome, Brain-gut and gut-brain axes, neuro-hormonal, neuralimmune and visceral sensitivity, Abstract, 2013
TARGETING MECHANISMS OF IRRITABLE BOWEL SYNDROME: EFFECTS OF LACTOBACILLUS REUTERI ON EPITHELIAL BARRIER DYSFUNCTION
2013-01-01
English, Medical management, Irritable Bowel Syndrome, Abstract, 2013
Mucosal immune biological markers in patients with Irritable Bowel Syndrome (IBS)
2012-09-08
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
Expression and hierarchic role of serotonin receptors in the control of the guinea pig distal colon peristalsis
2012-09-08
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
INTERFERON-GAMMA INCREASE IN THE MUCOSA OF IRRITABLE BOWEL SYNDROME AND ITS INTERPLAY WITH SEROTONIN METABOLISM AND MUCOSAL PERMEABILITY
2013-01-01
English, Irritable Bowel Syndrome, Brain-gut and gut-brain axes, neuro-hormonal, neuralimmune and visceral sensitivity, Abstract, 2013
PAR1 receptors mediate nerve activation by mucosal biopsy supernatants from Irritable Bowel Syndrome (IBS) but not from Ulcerative Colitis (UC) patients
2012-09-08
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
Postinfectious Irritable Bowel Syndrome (IBS): Follow-up at 16 year after a single outbreak of Salmonella gastroenteritis
2012-09-08
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
Evidence of RET/GDNF-related apolipoprotein B (APOB) activation and altered expression in patients with chronic intestinal pseudo-obstruction (CIPO)
2012-09-08
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
Mitochondropathy: A rare case of selective enteric myopathy
2012-09-07
English, Abstract, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
Communicating with patients: What should we tell them about pathophysiology?
2011-01-01
English, Presentation, Medical management, Aetiology / Causes, Classification, Functional disease, 2011
Effect on gut motility, permeability and sensitivity
2012-01-01
English, Presentation, Physiology, Gut microbiota, Neuro-Gastroenterology, European Society of Neurogastroenterology and Motility (ESNM), American Neurogastroenterology and Motility Society (ANMS), 2012
Neuroimmune interactions
2013-01-01
English, Presentation, Inflammation and inflammatory mechanisms, Cell signalling, Physiology, 2013
Mast cells: A central role?
2009-01-01
English, Presentation, Aetiology / Causes, Irritable Bowel Syndrome, Transmitters / signals / receptors / enteric nervous system, 2009
Consequences of increased intestinal permeability

European Association for Gastroenterology and Endoscopy and Nutrition (EAGEN), 2014
Permeability tests: Ready for prime time?

Presentation, 2014, Screening & Diagnosis, Oesophagus, Stomach & H. Pylori, Intestinal & Motility
Advances in translational science in neurogastroenterology and motility
2015-10-28
English, Presentation, Oesophagus, 2015, Neurogastroenterology & Motility, Primary Care, Young GI Track, Gut Microbiota
IBS is an organic GI disease that should be defined by biomarkers
2016-10-18
English, Presentation, 2016, Immunology, Neurogastroenterology & Motility, Paediatrics, Primary Care, Gut Microbiota
Barrier function and GI disease
2018-10-22
English, Presentation, Disease Mechanisms, Neurogastroenterology & Motility, 2018
Novel treatments
2018-10-24
English, Presentation, Neurogastroenterology & Motility, Primary Care, Young GI Track, 2018
ALFASIGMA - A worldwide perspective on diagnosis and management of diverticular disease: understanding similarities and differences (ALFASIGMA S.p.A)
2018-10-22
English, Presentation, Industry Sponsored Symposia, Industry Sponsored Symposia, 2018, Alfasigma S.p.A.